TOBRADEX

3MG/G+1MG/G OPH UNG 3,5G

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Cessation of marketing 11.01.2018 0225171
Placing on the market 01.02.2007
Resumption of marketing 18.03.2013
Interruption of marketing 20.02.2013 Lék se stejnými indikacemi s jiným složením

All reports are available in the Overview.

Back to list